Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionPegylated form of recombinant IL-10
Molecular Target Interleukin-10 (IL-10)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today